-
1
-
-
66949152096
-
Parkinson's disease
-
PID: 19524782, COI: 1:CAS:528:DC%2BD1MXnt1ans7w%3D
-
Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
-
(2009)
Lancet
, vol.373
, pp. 2055-2066
-
-
Lees, A.J.1
Hardy, J.2
Revesz, T.3
-
2
-
-
79957586330
-
Milestones in Parkinson's disease—clinical and pathologic features
-
PID: 21626546
-
Halliday G, Lees A, Stern M. Milestones in Parkinson's disease—clinical and pathologic features. Mov Disord 2011;26:1015-1021.
-
(2011)
Mov Disord
, vol.26
, pp. 1015-1021
-
-
Halliday, G.1
Lees, A.2
Stern, M.3
-
3
-
-
84873453232
-
The genetics of Parkinson's disease: progress and therapeutic implications
-
PID: 23389780, COI: 1:CAS:528:DC%2BC3sXjsVWhtr0%3D
-
Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord 2013;28:14-23.
-
(2013)
Mov Disord
, vol.28
, pp. 14-23
-
-
Singleton, A.B.1
Farrer, M.J.2
Bonifati, V.3
-
4
-
-
70549088602
-
Genome-wide association study reveals genetic risk underlying Parkinson's disease
-
PID: 19915575
-
Simón-Sánchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308-1312.
-
(2009)
Nat Genet
, vol.41
, pp. 1308-1312
-
-
Simón-Sánchez, J.1
Schulte, C.2
Bras, J.M.3
-
5
-
-
70549084415
-
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
-
PID: 19915576, COI: 1:CAS:528:DC%2BD1MXhsVWlsb7O
-
Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41:1303-1307.
-
(2009)
Nat Genet
, vol.41
, pp. 1303-1307
-
-
Satake, W.1
Nakabayashi, Y.2
Mizuta, I.3
-
6
-
-
71849086433
-
Clinical features of LRRK2 parkinsonism
-
PID: 20082991
-
Haugarvoll K, Wszolek ZK. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat Disord.2009;15(Suppl. 3):S205-S208.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, pp. S205-S208
-
-
Haugarvoll, K.1
Wszolek, Z.K.2
-
7
-
-
50049104725
-
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
-
PID: 18539534, COI: 1:CAS:528:DC%2BD1cXptVWju7o%3D
-
Healy DG, Falchi M, O'Sullivan SS, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008;7:583-590.
-
(2008)
Lancet Neurol
, vol.7
, pp. 583-590
-
-
Healy, D.G.1
Falchi, M.2
O'Sullivan, S.S.3
-
8
-
-
67249165702
-
Genetic neuropathology of Parkinson’s disease
-
PID: 18784814, COI: 1:CAS:528:DC%2BD1cXpt1Gnu7w%3D
-
Cookson MR, Hardy J, Lewis PA. Genetic neuropathology of Parkinson’s disease. Int J Clin Exp Pathol 2008;1:217-231.
-
(2008)
Int J Clin Exp Pathol
, vol.1
, pp. 217-231
-
-
Cookson, M.R.1
Hardy, J.2
Lewis, P.A.3
-
9
-
-
8844266996
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
-
PID: 15541308, COI: 1:CAS:528:DC%2BD2cXhtVKhurjK
-
Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
-
(2004)
Neuron
, vol.44
, pp. 595-600
-
-
Paisan-Ruiz, C.1
Jain, S.2
Evans, E.W.3
-
10
-
-
8844233579
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
-
PID: 15541309, COI: 1:CAS:528:DC%2BD2cXhtVKhurjL
-
Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
-
(2004)
Neuron
, vol.44
, pp. 601-607
-
-
Zimprich, A.1
Biskup, S.2
Leitner, P.3
-
11
-
-
0036196860
-
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
-
PID: 11891824, COI: 1:CAS:528:DC%2BD38XitlWqtrk%3D
-
Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
-
(2002)
Ann Neurol
, vol.51
, pp. 296-301
-
-
Funayama, M.1
Hasegawa, K.2
Kowa, H.3
Saito, M.4
Tsuji, S.5
Obata, F.6
-
12
-
-
28044460070
-
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
-
PID: 16269541, COI: 1:CAS:528:DC%2BD2MXht1KgsLrI
-
West AB, Moore DJ, Biskup S, et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 2005;102:16842-16847.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 16842-16847
-
-
West, A.B.1
Moore, D.J.2
Biskup, S.3
-
13
-
-
33746267531
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
-
PID: 16750377, COI: 1:CAS:528:DC%2BD28Xntl2ntrk%3D
-
Greggio E, Jain S, Kingsbury A, et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 2006;23:329-341.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 329-341
-
-
Greggio, E.1
Jain, S.2
Kingsbury, A.3
-
14
-
-
31144443248
-
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
-
PID: 16321986, COI: 1:CAS:528:DC%2BD28XktF2gtQ%3D%3D
-
Gloeckner CJ, Kinkl N, Schumacher A, et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006;15:223-232.
-
(2006)
Hum Mol Genet
, vol.15
, pp. 223-232
-
-
Gloeckner, C.J.1
Kinkl, N.2
Schumacher, A.3
-
15
-
-
33748993710
-
Kinase activity of mutant LRRK2 mediates neuronal toxicity
-
PID: 16980962, COI: 1:CAS:528:DC%2BD28XhtVSgu7fJ
-
Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 2006;9:1231-1233.
-
(2006)
Nat Neurosci
, vol.9
, pp. 1231-1233
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Dawson, V.L.4
Dawson, T.M.5
Ross, C.A.6
-
16
-
-
30344477641
-
LRRK2: a gene belonging to the ROCO family is implicated in the Parkinson's disease
-
Lesage S, Leutenegger AL, Brice A. LRRK2: a gene belonging to the ROCO family is implicated in the Parkinson's disease. Med Sci (Paris) 2005;21:1015-1017.
-
(2005)
Med Sci (Paris)
, vol.21
, pp. 1015-1017
-
-
Lesage, S.1
Leutenegger, A.L.2
Brice, A.3
-
17
-
-
33750931271
-
The Parkinson disease gene LRRK2: evolutionary and structural insights
-
PID: 16966681, COI: 1:CAS:528:DC%2BD28Xht1ejtbrP
-
Marin I. The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol Biol Evol 2006;23:2423-2433.
-
(2006)
Mol Biol Evol
, vol.23
, pp. 2423-2433
-
-
Marin, I.1
-
18
-
-
34247468302
-
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
-
PID: 17442267, COI: 1:CAS:528:DC%2BD2sXkslCisr4%3D
-
Lewis PA, Greggio E, Beilina A, Jain S, Baker A, Cookson MR. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 2007;357:668-671.
-
(2007)
Biochem Biophys Res Commun
, vol.357
, pp. 668-671
-
-
Lewis, P.A.1
Greggio, E.2
Beilina, A.3
Jain, S.4
Baker, A.5
Cookson, M.R.6
-
19
-
-
34548621385
-
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants
-
PID: 17623048, COI: 1:CAS:528:DC%2BD2sXhtF2qu7fM
-
Li X, Tan YC, Poulose S, Olanow CW, Huang XY, Yue Z. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem 2007;103:238-247.
-
(2007)
J Neurochem
, vol.103
, pp. 238-247
-
-
Li, X.1
Tan, Y.C.2
Poulose, S.3
Olanow, C.W.4
Huang, X.Y.5
Yue, Z.6
-
20
-
-
34548604567
-
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
-
PID: 17706965, COI: 1:CAS:528:DC%2BD2sXhtVOlsbfM
-
Guo L, Gandhi PN, Wang W, Petersen RB, Wilson-Delfosse AL, Chen SG. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res 2007;313:3658-3670.
-
(2007)
Exp Cell Res
, vol.313
, pp. 3658-3670
-
-
Guo, L.1
Gandhi, P.N.2
Wang, W.3
Petersen, R.B.4
Wilson-Delfosse, A.L.5
Chen, S.G.6
-
21
-
-
80051611506
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding
-
PID: 21858031, COI: 1:CAS:528:DC%2BC3MXhtFGhtLvI
-
Taymans JM, Vancraenenbroeck R, Ollikainen P, et al. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS One 2011;6:e23207.
-
(2011)
PLoS One
, vol.6
, pp. e23207
-
-
Taymans, J.M.1
Vancraenenbroeck, R.2
Ollikainen, P.3
-
22
-
-
77749255337
-
Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: characterization of the kinase and GTPase activities
-
PID: 20146535, COI: 1:CAS:528:DC%2BC3cXhslKntLY%3D
-
Liu M, Dobson B, Glicksman MA, Yue Z, Stein RL. Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: characterization of the kinase and GTPase activities. Biochemistry 2010;49:2008-2017.
-
(2010)
Biochemistry
, vol.49
, pp. 2008-2017
-
-
Liu, M.1
Dobson, B.2
Glicksman, M.A.3
Yue, Z.4
Stein, R.L.5
-
23
-
-
33846818834
-
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
-
PID: 17260967, COI: 1:CAS:528:DC%2BD2sXkvV2itQ%3D%3D
-
Ito G, Okai T, Fujino G, et al. GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 2007;46:1380-1388.
-
(2007)
Biochemistry
, vol.46
, pp. 1380-1388
-
-
Ito, G.1
Okai, T.2
Fujino, G.3
-
24
-
-
47749114984
-
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
-
PID: 18397888, COI: 1:CAS:528:DC%2BD1cXmslOitLk%3D
-
Greggio E, Zambrano I, Kaganovich A, et al. The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem.2008;283:16906-16914.
-
(2008)
J Biol Chem
, vol.283
, pp. 16906-16914
-
-
Greggio, E.1
Zambrano, I.2
Kaganovich, A.3
-
25
-
-
70449732284
-
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
-
PID: 19733152, COI: 1:CAS:528:DC%2BD1MXht1Gks7jJ
-
Greggio E, Taymans JM, Zhen EY, et al. The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. Biochem Biophys Res Commun 2009;389:449-454.
-
(2009)
Biochem Biophys Res Commun
, vol.389
, pp. 449-454
-
-
Greggio, E.1
Taymans, J.M.2
Zhen, E.Y.3
-
26
-
-
72749105819
-
Identification of the autophosphorylation sites of LRRK2
-
PID: 19824698, COI: 1:CAS:528:DC%2BD1MXhtlagtrvF
-
Kamikawaji S, Ito G, Iwatsubo T. Identification of the autophosphorylation sites of LRRK2. Biochemistry 2009;48:10963-10975.
-
(2009)
Biochemistry
, vol.48
, pp. 10963-10975
-
-
Kamikawaji, S.1
Ito, G.2
Iwatsubo, T.3
-
27
-
-
77956529777
-
Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2
-
PID: 20595391, COI: 1:CAS:528:DC%2BC3cXhtFCns7fE
-
Li X, Moore DJ, Xiong Y, Dawson TM, Dawson VL. Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2. J Biol Chem 2010;285:29569-29576.
-
(2010)
J Biol Chem
, vol.285
, pp. 29569-29576
-
-
Li, X.1
Moore, D.J.2
Xiong, Y.3
Dawson, T.M.4
Dawson, V.L.5
-
28
-
-
77950631558
-
Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2
-
PID: 20108944, COI: 1:CAS:528:DC%2BC3cXitFejt7g%3D
-
Gloeckner CJ, Boldt K, von Zweydorf F, et al. Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J Proteome Res 2010;9:1738-1745.
-
(2010)
J Proteome Res
, vol.9
, pp. 1738-1745
-
-
Gloeckner, C.J.1
Boldt, K.2
von Zweydorf, F.3
-
29
-
-
84860389765
-
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities
-
PID: 21806997, COI: 1:CAS:528:DC%2BC3MXhtVGkt77N
-
Webber PJ, Smith AD, Sen S, Renfrow MB, Mobley JA, West AB. Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. J Mol Biol 2011;412:94-110.
-
(2011)
J Mol Biol
, vol.412
, pp. 94-110
-
-
Webber, P.J.1
Smith, A.D.2
Sen, S.3
Renfrow, M.B.4
Mobley, J.A.5
West, A.B.6
-
30
-
-
84866652723
-
The GTPase function of LRRK2
-
PID: 22988866, COI: 1:CAS:528:DC%2BC38XhtlOjur%2FI
-
Taymans JM. The GTPase function of LRRK2. Biochem Soc Trans 2012;40:1063-1069.
-
(2012)
Biochem Soc Trans
, vol.40
, pp. 1063-1069
-
-
Taymans, J.M.1
-
31
-
-
33646151866
-
LRRK2 in Parkinson's disease: protein domains and functional insights
-
PID: 16616379, COI: 1:CAS:528:DC%2BD28XktVehtb0%3D
-
Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 2006;29:286-293.
-
(2006)
Trends Neurosci
, vol.29
, pp. 286-293
-
-
Mata, I.F.1
Wedemeyer, W.J.2
Farrer, M.J.3
Taylor, J.P.4
Gallo, K.A.5
-
32
-
-
78149446290
-
ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2
-
PID: 21048939
-
Haebig K, Gloeckner CJ, Miralles MG, et al. ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS One 2010;5:e13762.
-
(2010)
PLoS One
, vol.5
, pp. e13762
-
-
Haebig, K.1
Gloeckner, C.J.2
Miralles, M.G.3
-
33
-
-
84859187983
-
GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1
-
PID: 22363216, COI: 1:CAS:528:DC%2BC38XivVWgsr0%3D
-
Stafa K, Trancikova A, Webber PJ, Glauser L, West AB, Moore DJ. GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1. PLoS Genet 2012;8:e1002526.
-
(2012)
PLoS Genet
, vol.8
, pp. e1002526
-
-
Stafa, K.1
Trancikova, A.2
Webber, P.J.3
Glauser, L.4
West, A.B.5
Moore, D.J.6
-
34
-
-
84858050446
-
ArfGAP1 is a GTPase activating protein for LRRK2: reciprocal regulation of ArfGAP1 by LRRK2
-
PID: 22423108, COI: 1:CAS:528:DC%2BC38XktlOltL4%3D
-
Xiong Y, Yuan C, Chen R, Dawson TM, Dawson VL. ArfGAP1 is a GTPase activating protein for LRRK2: reciprocal regulation of ArfGAP1 by LRRK2. J Neurosci 2012;32:3877-3886.
-
(2012)
J Neurosci
, vol.32
, pp. 3877-3886
-
-
Xiong, Y.1
Yuan, C.2
Chen, R.3
Dawson, T.M.4
Dawson, V.L.5
-
35
-
-
84861232484
-
Mechanisms of LRRK2-mediated neurodegeneration
-
PID: 22441981, COI: 1:CAS:528:DC%2BC38XmsF2jsb0%3D
-
Tsika E, Moore DJ. Mechanisms of LRRK2-mediated neurodegeneration. Curr Neurol Neurosci Rep 2012;12:251-260.
-
(2012)
Curr Neurol Neurosci Rep
, vol.12
, pp. 251-260
-
-
Tsika, E.1
Moore, D.J.2
-
36
-
-
67349250817
-
It takes two to tango - regulation of G proteins by dimerization
-
PID: 19424291, COI: 1:CAS:528:DC%2BD1MXlsF2lsLg%3D
-
Gasper R, Meyer S, Gotthardt K, Sirajuddin M, Wittinghofer A. It takes two to tango - regulation of G proteins by dimerization. Nat Rev Mol Cell Biol 2009;10:423-429.
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 423-429
-
-
Gasper, R.1
Meyer, S.2
Gotthardt, K.3
Sirajuddin, M.4
Wittinghofer, A.5
-
37
-
-
77954197844
-
Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation
-
PID: 20515039, COI: 1:CAS:528:DC%2BC3cXnt1Cmu7k%3D
-
Berger Z, Smith KA, Lavoie MJ. Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 2010;49:5511-5523.
-
(2010)
Biochemistry
, vol.49
, pp. 5511-5523
-
-
Berger, Z.1
Smith, K.A.2
Lavoie, M.J.3
-
38
-
-
73649120624
-
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization
-
PID: 19826009, COI: 1:CAS:528:DC%2BD1MXhsFyiurvL
-
Sen S, Webber PJ, West AB. Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J Biol Chem 2009;284:36346-36356.
-
(2009)
J Biol Chem
, vol.284
, pp. 36346-36356
-
-
Sen, S.1
Webber, P.J.2
West, A.B.3
-
39
-
-
84865583070
-
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers
-
PID: 22952686, COI: 1:CAS:528:DC%2BC38Xht12ht7fP
-
Civiero L, Vancraenenbroeck R, Belluzzi E, et al. Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS One 2012;7:e43472.
-
(2012)
PLoS One
, vol.7
, pp. e43472
-
-
Civiero, L.1
Vancraenenbroeck, R.2
Belluzzi, E.3
-
40
-
-
45549085874
-
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
-
PID: 18214993, COI: 1:CAS:528:DC%2BD1cXnt1ektbg%3D
-
Gandhi PN, Wang X, Zhu X, Chen SG, Wilson-Delfosse AL. The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 2008;86:1711-1720.
-
(2008)
J Neurosci Res
, vol.86
, pp. 1711-1720
-
-
Gandhi, P.N.1
Wang, X.2
Zhu, X.3
Chen, S.G.4
Wilson-Delfosse, A.L.5
-
41
-
-
84863012282
-
LRRK2 Parkinson disease mutations enhance its microtubule association
-
PID: 22080837, COI: 1:CAS:528:DC%2BC38XhsVant7g%3D
-
Kett LR, Boassa D, Ho CC, et al. LRRK2 Parkinson disease mutations enhance its microtubule association. Hum Mol Genet 2012;21:890-899.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 890-899
-
-
Kett, L.R.1
Boassa, D.2
Ho, C.C.3
-
42
-
-
84876318823
-
Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
-
PID: 23318930, COI: 1:CAS:528:DC%2BC3sXhvFaju7w%3D
-
Caesar M, Zach S, Carlson CB, Brockmann K, Gasser T, Gillardon F. Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration. Neurobiol Dis 2013;54:280-288.
-
(2013)
Neurobiol Dis
, vol.54
, pp. 280-288
-
-
Caesar, M.1
Zach, S.2
Carlson, C.B.3
Brockmann, K.4
Gasser, T.5
Gillardon, F.6
-
43
-
-
68949218403
-
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?
-
Gillardon F. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration? J Neurochem 2009;110:1514-1522.
-
(2009)
J Neurochem
, vol.110
, pp. 1514-1522
-
-
Gillardon, F.1
-
44
-
-
77956674229
-
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
-
PID: 20642453, COI: 1:CAS:528:DC%2BC3cXhtVyrtbzK
-
Nichols RJ, Dzamko N, Morrice NA, et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem J 2010;430:393-404.
-
(2010)
Biochem J
, vol.430
, pp. 393-404
-
-
Nichols, R.J.1
Dzamko, N.2
Morrice, N.A.3
-
45
-
-
77956655427
-
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization
-
PID: 20659021, COI: 1:CAS:528:DC%2BC3cXhtVyrtbzL
-
Dzamko N, Deak M, Hentati F, et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem J 2010;430:405-413.
-
(2010)
Biochem J
, vol.430
, pp. 405-413
-
-
Dzamko, N.1
Deak, M.2
Hentati, F.3
-
46
-
-
77349113121
-
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2
-
PID: 20067578, COI: 1:CAS:528:DC%2BC3cXjsFarsrs%3D
-
Hsu CH, Chan D, Greggio E, et al. MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem 2010;112:1593-1604.
-
(2010)
J Neurochem
, vol.112
, pp. 1593-1604
-
-
Hsu, C.H.1
Chan, D.2
Greggio, E.3
-
47
-
-
70349576902
-
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways
-
PID: 19625296, COI: 1:CAS:528:DC%2BD1MXhtFyhu77O
-
Sancho RM, Law BM, Harvey K. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum Mol Genet 2009;18:3955-3968.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 3955-3968
-
-
Sancho, R.M.1
Law, B.M.2
Harvey, K.3
-
48
-
-
78649389313
-
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
-
PID: 21088684, COI: 1:CAS:528:DC%2BC3cXhsVersLbO
-
Cookson MR. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 2010;11:791-797.
-
(2010)
Nat Rev Neurosci
, vol.11
, pp. 791-797
-
-
Cookson, M.R.1
-
49
-
-
77953090478
-
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice
-
PID: 20457918, COI: 1:CAS:528:DC%2BC3cXntFWltrc%3D
-
Tong Y, Yamaguchi H, Giaime E, et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 2010;107:9879-9884.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 9879-9884
-
-
Tong, Y.1
Yamaguchi, H.2
Giaime, E.3
-
50
-
-
80053968304
-
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
-
PID: 21828077, COI: 1:CAS:528:DC%2BC3MXht1yltrnI
-
Herzig MC, Kolly C, Persohn E, et al. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 2011;20:4209-4223.
-
(2011)
Hum Mol Genet
, vol.20
, pp. 4209-4223
-
-
Herzig, M.C.1
Kolly, C.2
Persohn, E.3
-
51
-
-
84873281274
-
RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk
-
PID: 23395371, COI: 1:CAS:528:DC%2BC3sXitFChs7o%3D
-
MacLeod DA, Rhinn H, Kuwahara T, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013;77:425-439.
-
(2013)
Neuron
, vol.77
, pp. 425-439
-
-
MacLeod, D.A.1
Rhinn, H.2
Kuwahara, T.3
-
52
-
-
79951534656
-
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool
-
PID: 21307259, COI: 1:CAS:528:DC%2BC3MXit1antLw%3D
-
Piccoli G, Condliffe SB, Bauer M, et al. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci 2011;31:2225-2237.
-
(2011)
J Neurosci
, vol.31
, pp. 2225-2237
-
-
Piccoli, G.1
Condliffe, S.B.2
Bauer, M.3
-
53
-
-
77957794336
-
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
-
PID: 20659558, COI: 1:CAS:528:DC%2BC3cXhtlSnurvK
-
Melrose HL, Dachsel JC, Behrouz B, et al. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 2010;40:503-517.
-
(2010)
Neurobiol Dis
, vol.40
, pp. 503-517
-
-
Melrose, H.L.1
Dachsel, J.C.2
Behrouz, B.3
-
54
-
-
76149134717
-
Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S
-
PID: 20130188, COI: 1:CAS:528:DC%2BC3cXitV2jurY%3D
-
Li X, Patel JC, Wang J, et al. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 2010;30:1788-1797.
-
(2010)
J Neurosci
, vol.30
, pp. 1788-1797
-
-
Li, X.1
Patel, J.C.2
Wang, J.3
-
55
-
-
84896736721
-
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
-
PID: 24464040, COI: 1:CAS:528:DC%2BC2cXht1yju7c%3D
-
Parisiadou L, Yu J, Sgobio C, et al. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat Neurosci 2014;17:367-376.
-
(2014)
Nat Neurosci
, vol.17
, pp. 367-376
-
-
Parisiadou, L.1
Yu, J.2
Sgobio, C.3
-
56
-
-
33751256567
-
The familial Parkinsonism gene LRRK2 regulates neurite process morphology
-
PID: 17114044, COI: 1:CAS:528:DC%2BD28XhtlSmtLnM
-
MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52:587-593.
-
(2006)
Neuron
, vol.52
, pp. 587-593
-
-
MacLeod, D.1
Dowman, J.2
Hammond, R.3
Leete, T.4
Inoue, K.5
Abeliovich, A.6
-
57
-
-
70449377127
-
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis
-
PID: 19890007, COI: 1:CAS:528:DC%2BD1MXhsVSmsbnI
-
Parisiadou L, Xie C, Cho HJ, et al. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 2009;29:13971-13980.
-
(2009)
J Neurosci
, vol.29
, pp. 13971-13980
-
-
Parisiadou, L.1
Xie, C.2
Cho, H.J.3
-
58
-
-
77954623892
-
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
-
PID: 20669305
-
Aasly JO, Vilarino-Guell C, Dachsel JC, et al. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Mov Disord 2010;25:2156-2163.
-
(2010)
Mov Disord
, vol.25
, pp. 2156-2163
-
-
Aasly, J.O.1
Vilarino-Guell, C.2
Dachsel, J.C.3
-
59
-
-
69149089036
-
Molecular pathogenesis of Parkinson disease: insights from genetic studies
-
PID: 19631006
-
Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 2009;11:e22.
-
(2009)
Expert Rev Mol Med
, vol.11
, pp. e22
-
-
Gasser, T.1
-
60
-
-
33645160640
-
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor
-
PID: 16272257, COI: 1:STN:280:DC%2BD2MrptlGhug%3D%3D
-
Goldwurm S, Di Fonzo A, Simons EJ, et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 2005;42:e65.
-
(2005)
J Med Genet
, vol.42
, pp. e65
-
-
Goldwurm, S.1
Di Fonzo, A.2
Simons, E.J.3
-
61
-
-
19944432921
-
A common LRRK2 mutation in idiopathic Parkinson's disease
-
PID: 15680457, COI: 1:CAS:528:DC%2BD2MXoslWitQ%3D%3D
-
Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415-416.
-
(2005)
Lancet
, vol.365
, pp. 415-416
-
-
Gilks, W.P.1
Abou-Sleiman, P.M.2
Gandhi, S.3
-
62
-
-
32244446461
-
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
-
PID: 16298482, COI: 1:CAS:528:DC%2BD28XhtlGhtb0%3D
-
Infante J, Rodriguez E, Combarros O, et al. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Neurosci Lett 2006;395:224-226.
-
(2006)
Neurosci Lett
, vol.395
, pp. 224-226
-
-
Infante, J.1
Rodriguez, E.2
Combarros, O.3
-
63
-
-
28544446980
-
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
-
PID: 16149095
-
Bras JM, Guerreiro RJ, Ribeiro MH, et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 2005;20:1653-1655.
-
(2005)
Mov Disord
, vol.20
, pp. 1653-1655
-
-
Bras, J.M.1
Guerreiro, R.J.2
Ribeiro, M.H.3
-
64
-
-
31344439221
-
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
-
PID: 16436782, COI: 1:CAS:528:DC%2BD28XnslWisw%3D%3D
-
Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006;354:424-425.
-
(2006)
N Engl J Med
, vol.354
, pp. 424-425
-
-
Ozelius, L.J.1
Senthil, G.2
Saunders-Pullman, R.3
-
65
-
-
31344432937
-
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
-
PID: 16436781, COI: 1:CAS:528:DC%2BD28XnslWisg%3D%3D
-
Lesage S, Dürr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006;354:422-423.
-
(2006)
N Engl J Med
, vol.354
, pp. 422-423
-
-
Lesage, S.1
Dürr, A.2
Tazir, M.3
-
66
-
-
84874967177
-
Type II Kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S
-
Liu M, Bender SA, Cuny GD, Sherman W, Glicksman M, Ray SS. Type II Kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S. Biochemistry 2013;12:1725-1736.
-
(2013)
Biochemistry
, vol.12
, pp. 1725-1736
-
-
Liu, M.1
Bender, S.A.2
Cuny, G.D.3
Sherman, W.4
Glicksman, M.5
Ray, S.S.6
-
67
-
-
34447118788
-
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
-
PID: 17447891, COI: 1:CAS:528:DC%2BD2sXmvFKksr4%3D
-
Jaleel M, Nichols RJ, Deak M, et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007;405:307-317.
-
(2007)
Biochem J
, vol.405
, pp. 307-317
-
-
Jaleel, M.1
Nichols, R.J.2
Deak, M.3
-
68
-
-
58149158022
-
Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays
-
Anand VS, Reichling LJ, Lipinski K, et al. Investigation of leucine-rich repeat kinase 2: enzymological properties and novel assays. FEBS J 2009;276:466-478.
-
(2009)
FEBS J
, vol.276
, pp. 466-478
-
-
Anand, V.S.1
Reichling, L.J.2
Lipinski, K.3
-
69
-
-
34548432121
-
Rubio de la Torre E, Delgado A, Perez-Tur J, Hilfiker S. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
-
PID: 17584768, COI: 1:CAS:528:DC%2BD2sXpvVWqtro%3D
-
Luzon-Toro B, Rubio de la Torre E, Delgado A, Perez-Tur J, Hilfiker S. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Hum Mol Genet 2007;16:2031-2039.
-
(2007)
Hum Mol Genet
, vol.16
, pp. 2031-2039
-
-
Luzon-Toro, B.1
-
70
-
-
34447294546
-
Apoptotic mechanisms in mutant LRRK2-mediated cell death
-
PID: 17409193, COI: 1:CAS:528:DC%2BD2sXnsl2jtb8%3D
-
Iaccarino C, Crosio C, Vitale C, Sanna G, Carri MT, Barone P. Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum Mol Genet 2007;16:1319-1326.
-
(2007)
Hum Mol Genet
, vol.16
, pp. 1319-1326
-
-
Iaccarino, C.1
Crosio, C.2
Vitale, C.3
Sanna, G.4
Carri, M.T.5
Barone, P.6
-
71
-
-
57749185024
-
Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
-
PID: 19027715, COI: 1:CAS:528:DC%2BD1cXhsFClsrrM
-
Covy JP, Giasson BI. Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. Biochem Biophys Res Commun 2009;378:473-477.
-
(2009)
Biochem Biophys Res Commun
, vol.378
, pp. 473-477
-
-
Covy, J.P.1
Giasson, B.I.2
-
72
-
-
77649328234
-
The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation
-
PID: 20090955
-
Kumar A, Greggio E, Beilina A, et al. The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS One 2010;5:e8730.
-
(2010)
PLoS One
, vol.5
, pp. e8730
-
-
Kumar, A.1
Greggio, E.2
Beilina, A.3
-
73
-
-
84864743687
-
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
-
PID: 22612223, COI: 1:CAS:528:DC%2BC38XhtFShsL3O
-
Rudenko IN, Kaganovich A, Hauser DN, et al. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation. Biochem J 2012;446:99-111.
-
(2012)
Biochem J
, vol.446
, pp. 99-111
-
-
Rudenko, I.N.1
Kaganovich, A.2
Hauser, D.N.3
-
74
-
-
20444420103
-
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
-
PID: 15880653, COI: 1:CAS:528:DC%2BD2MXlslKks7k%3D
-
Funayama M, Hasegawa K, Ohta E, et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005;57:918-921.
-
(2005)
Ann Neurol
, vol.57
, pp. 918-921
-
-
Funayama, M.1
Hasegawa, K.2
Ohta, E.3
-
75
-
-
51949090816
-
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
-
Imai Y, Gehrke S, Wang HQ, et al. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 2008;17:2432-2443
-
(2008)
EMBO J
, vol.17
, pp. 2432-2443
-
-
Imai, Y.1
Gehrke, S.2
Wang, H.Q.3
-
76
-
-
84883477432
-
Differential effects of familial Parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation
-
PID: 23924436, COI: 1:CAS:528:DC%2BC3sXht1ars7rN
-
Kamikawaji S, Ito G, Sano T, Iwatsubo T. Differential effects of familial Parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation. Biochemistry 2013;52:6052-6062.
-
(2013)
Biochemistry
, vol.52
, pp. 6052-6062
-
-
Kamikawaji, S.1
Ito, G.2
Sano, T.3
Iwatsubo, T.4
-
77
-
-
84900463278
-
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity
-
PID: 24695735, COI: 1:CAS:528:DC%2BC2cXnslGgtb4%3D
-
Ray S, Bender S, Kang S, Lin R, Glicksman MA, Liu M. The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity. J Biol Chem 2014;289:13042-13053.
-
(2014)
J Biol Chem
, vol.289
, pp. 13042-13053
-
-
Ray, S.1
Bender, S.2
Kang, S.3
Lin, R.4
Glicksman, M.A.5
Liu, M.6
-
78
-
-
77953395313
-
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions
-
Greggio E, Cookson MR. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009;1.
-
(2009)
ASN Neuro
, pp. 1
-
-
Greggio, E.1
Cookson, M.R.2
-
79
-
-
42049094200
-
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
-
PID: 18337586, COI: 1:STN:280:DC%2BD1c3ltFOiuw%3D%3D
-
Haugarvoll K, Rademakers R, Kachergus JM, et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008;70:1456-1460.
-
(2008)
Neurology
, vol.70
, pp. 1456-1460
-
-
Haugarvoll, K.1
Rademakers, R.2
Kachergus, J.M.3
-
80
-
-
33845204840
-
Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques
-
PID: 16991141
-
Simon-Sanchez J, Marti-Masso JF, Sanchez-Mut JV, et al. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques. Mov Disord 2006;21:1954-1959.
-
(2006)
Mov Disord
, vol.21
, pp. 1954-1959
-
-
Simon-Sanchez, J.1
Marti-Masso, J.F.2
Sanchez-Mut, J.V.3
-
81
-
-
28344457936
-
Lrrk2 pathogenic substitutions in Parkinson's disease
-
PID: 16172858, COI: 1:CAS:528:DC%2BD2MXht1KnsLfK
-
Mata IF, Kachergus JM, Taylor JP, et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005;6:171-177.
-
(2005)
Neurogenetics
, vol.6
, pp. 171-177
-
-
Mata, I.F.1
Kachergus, J.M.2
Taylor, J.P.3
-
82
-
-
24644486896
-
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
-
PID: 16157909, COI: 1:CAS:528:DC%2BD2MXovVOhsro%3D
-
Zabetian CP, Samii A, Mosley AD, et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005;65:741-744.
-
(2005)
Neurology
, vol.65
, pp. 741-744
-
-
Zabetian, C.P.1
Samii, A.2
Mosley, A.D.3
-
83
-
-
33750331692
-
LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP
-
PID: 17060595
-
Spanaki C, Latsoudis H, Plaitakis A. LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology 2006;67:1518-1519.
-
(2006)
Neurology
, vol.67
, pp. 1518-1519
-
-
Spanaki, C.1
Latsoudis, H.2
Plaitakis, A.3
-
84
-
-
67549117509
-
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
-
PID: 18952485
-
Ross OA, Spanaki C, Griffith A, et al. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism Relat Disord 2009;15:466-467.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, pp. 466-467
-
-
Ross, O.A.1
Spanaki, C.2
Griffith, A.3
-
85
-
-
84883290105
-
Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants
-
PID: 23726462
-
Zhang L, Quadri M, Guedes LC, et al. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants. Parkinsonism Relat Disord 2013;19:897-900.
-
(2013)
Parkinsonism Relat Disord
, vol.19
, pp. 897-900
-
-
Zhang, L.1
Quadri, M.2
Guedes, L.C.3
-
86
-
-
84875277277
-
Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations
-
PID: 23462481
-
Puschmann A. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 2013;19:407-415.
-
(2013)
Parkinsonism Relat Disord
, vol.19
, pp. 407-415
-
-
Puschmann, A.1
-
87
-
-
40349101849
-
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
-
PID: 18230735, COI: 1:CAS:528:DC%2BD1cXhvFCit7g%3D
-
Deng J, Lewis PA, Greggio E, Sluch E, Beilina A, Cookson MR. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A 2008;105:1499-1504.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 1499-1504
-
-
Deng, J.1
Lewis, P.A.2
Greggio, E.3
Sluch, E.4
Beilina, A.5
Cookson, M.R.6
-
88
-
-
78650685500
-
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
-
PID: 21073465, COI: 1:CAS:528:DC%2BC3MXhtFGqur4%3D
-
Daniels V, Vancraenenbroeck R, Law BM, et al. Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. J Neurochem 2011;116:304-315.
-
(2011)
J Neurochem
, vol.116
, pp. 304-315
-
-
Daniels, V.1
Vancraenenbroeck, R.2
Law, B.M.3
-
89
-
-
84896522656
-
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain
-
PID: 24591621, COI: 1:CAS:528:DC%2BC2cXjtlyrtbc%3D
-
Liao J, Wu CX, Burlak C, et al. Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain. Proc Natl Acad Sci U S A 2014;111:4055-4060.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 4055-4060
-
-
Liao, J.1
Wu, C.X.2
Burlak, C.3
-
90
-
-
71849112162
-
The R1441C mutation alters the folding properties of the ROC domain of LRRK2
-
PID: 19781641, COI: 1:CAS:528:DC%2BD1MXhsVKntrbM
-
Li Y, Dunn L, Greggio E, et al. The R1441C mutation alters the folding properties of the ROC domain of LRRK2. Biochim Biophys Acta 2009;1792:1194-1197.
-
(2009)
Biochim Biophys Acta
, vol.1792
, pp. 1194-1197
-
-
Li, Y.1
Dunn, L.2
Greggio, E.3
-
91
-
-
49949099269
-
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase
-
PID: 18650931, COI: 1:CAS:528:DC%2BD1cXhtVSjsrrN
-
Gotthardt K, Weyand M, Kortholt A, Van Haastert PJ, Wittinghofer A. Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J 2008;27:2239-2249
-
(2008)
EMBO J
, vol.27
, pp. 2239-2249
-
-
Gotthardt, K.1
Weyand, M.2
Kortholt, A.3
Van Haastert, P.J.4
Wittinghofer, A.5
-
92
-
-
84886466822
-
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
-
PID: 23937259, COI: 1:CAS:528:DC%2BC3sXhs1KqtLrK
-
Lobbestael E, Zhao J, Rudenko IN, et al. Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle. Biochem J 2013;456:119-128.
-
(2013)
Biochem J
, vol.456
, pp. 119-128
-
-
Lobbestael, E.1
Zhao, J.2
Rudenko, I.N.3
-
93
-
-
75949122054
-
The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population
-
PID: 19854095
-
Kim JM, Lee JY, Kim HJ, et al. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Parkinsonism Relat Disord 2010;16:85-88.
-
(2010)
Parkinsonism Relat Disord
, vol.16
, pp. 85-88
-
-
Kim, J.M.1
Lee, J.Y.2
Kim, H.J.3
-
94
-
-
33846358949
-
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence
-
PID: 17019612, COI: 1:CAS:528:DC%2BD2sXnsF2isQ%3D%3D
-
Tan EK, Zhao Y, Skipper L, et al. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 2007;120:857-863.
-
(2007)
Hum Genet
, vol.120
, pp. 857-863
-
-
Tan, E.K.1
Zhao, Y.2
Skipper, L.3
-
95
-
-
84874244284
-
LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China
-
PID: 22981185
-
Fu X, Zheng Y, Hong H, et al. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China. Parkinsonism Relat Disord 2013;19:397-398.
-
(2013)
Parkinsonism Relat Disord
, vol.19
, pp. 397-398
-
-
Fu, X.1
Zheng, Y.2
Hong, H.3
-
96
-
-
33846587090
-
A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan
-
PID: 17187665
-
Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 2006;6:47.
-
(2006)
BMC Neurol
, vol.6
, pp. 47
-
-
Fung, H.C.1
Chen, C.M.2
Hardy, J.3
Singleton, A.B.4
Wu, Y.R.5
-
97
-
-
33847226901
-
Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population
-
PID: 17314670, COI: 1:CAS:528:DC%2BD2sXhvFWrt7c%3D
-
Funayama M, Li Y, Tomiyama H, et al. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 2007;18:273-275.
-
(2007)
Neuroreport
, vol.18
, pp. 273-275
-
-
Funayama, M.1
Li, Y.2
Tomiyama, H.3
-
98
-
-
48949092066
-
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
-
PID: 18412265, COI: 1:CAS:528:DC%2BD1cXhtVKnsrnJ
-
Ross OA, Wu YR, Lee MC, et al. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008;64:88-92.
-
(2008)
Ann Neurol
, vol.64
, pp. 88-92
-
-
Ross, O.A.1
Wu, Y.R.2
Lee, M.C.3
-
99
-
-
53749090842
-
LRRK2 R1628P increases risk of Parkinson's disease: replication evidence
-
PID: 18781329, COI: 1:CAS:528:DC%2BD1cXht1art7jK
-
Tan EK, Tan LC, Lim HQ, et al. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum Genet 2008;124:287-288.
-
(2008)
Hum Genet
, vol.124
, pp. 287-288
-
-
Tan, E.K.1
Tan, L.C.2
Lim, H.Q.3
-
100
-
-
70349267492
-
LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China
-
PID: 19699188, COI: 1:CAS:528:DC%2BD1MXhtFyqsb%2FK
-
Yu L, Hu F, Zou X, et al. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China. Brain Res 2009;1296:113-116.
-
(2009)
Brain Res
, vol.1296
, pp. 113-116
-
-
Yu, L.1
Hu, F.2
Zou, X.3
-
101
-
-
70450202383
-
LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
-
PID: 19672984
-
Zhang Z, Burgunder JM, An X, et al. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Mov Disord 2009;24:1902-1905.
-
(2009)
Mov Disord
, vol.24
, pp. 1902-1905
-
-
Zhang, Z.1
Burgunder, J.M.2
An, X.3
-
102
-
-
80052967403
-
Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case–control study
-
PID: 21885347, COI: 1:CAS:528:DC%2BC3MXht1ant7zP
-
Ross OA, Soto-Ortolaza AI, Heckman MG, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case–control study. Lancet Neurol 2011;10:898-908.
-
(2011)
Lancet Neurol
, vol.10
, pp. 898-908
-
-
Ross, O.A.1
Soto-Ortolaza, A.I.2
Heckman, M.G.3
-
103
-
-
77949514432
-
The WD40 domain is required for LRRK2 neurotoxicity
-
PID: 20041156
-
Jorgensen ND, Peng Y, Ho CC, et al. The WD40 domain is required for LRRK2 neurotoxicity. PLoS One 2009;4:e8463.
-
(2009)
PLoS One
, vol.4
, pp. e8463
-
-
Jorgensen, N.D.1
Peng, Y.2
Ho, C.C.3
-
104
-
-
84860380154
-
First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation
-
PID: 22154298
-
Puschmann A, Englund E, Ross OA, et al. First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation. Parkinsonism Relat Disord 2012;18:332-338.
-
(2012)
Parkinsonism Relat Disord
, vol.18
, pp. 332-338
-
-
Puschmann, A.1
Englund, E.2
Ross, O.A.3
-
106
-
-
79955043145
-
LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population
-
PID: 21159540, COI: 1:CAS:528:DC%2BC3MXnt12nsro%3D
-
Chen L, Zhang S, Liu Y, et al. LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population. Parkinsonism Relat Disord 2011;17:291-292.
-
(2011)
Parkinsonism Relat Disord
, vol.17
, pp. 291-292
-
-
Chen, L.1
Zhang, S.2
Liu, Y.3
-
107
-
-
77951876814
-
Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study
-
PID: 20186690, COI: 1:CAS:528:DC%2BC3cXnt1CjtLY%3D
-
Tan EK, Peng R, Teo YY, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010;31:561-568.
-
(2010)
Hum Mutat
, vol.31
, pp. 561-568
-
-
Tan, E.K.1
Peng, R.2
Teo, Y.Y.3
-
108
-
-
84861915918
-
Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe
-
PID: 22415848, COI: 1:CAS:528:DC%2BC38XotVant7s%3D
-
Rubio JP, Topp S, Warren L, et al. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. Hum Mutat 2012;33:1087-1098.
-
(2012)
Hum Mutat
, vol.33
, pp. 1087-1098
-
-
Rubio, J.P.1
Topp, S.2
Warren, L.3
-
109
-
-
84885187895
-
The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
-
Heckman MG, Elbaz A, Soto-Ortolaza AI, et al. The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging 2014;35:266 e5- e14.
-
(2014)
Neurobiol Aging
, vol.35
, Issue.266
, pp. e5-e14
-
-
Heckman, M.G.1
Elbaz, A.2
Soto-Ortolaza, A.I.3
-
110
-
-
84874541806
-
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
-
PID: 23241358, COI: 1:CAS:528:DC%2BC3sXivFKqtL0%3D
-
Biosa A, Trancikova A, Civiero L, et al. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2. Hum Mol Genet 2013;22:1140-1156.
-
(2013)
Hum Mol Genet
, vol.22
, pp. 1140-1156
-
-
Biosa, A.1
Trancikova, A.2
Civiero, L.3
-
111
-
-
77952391573
-
GTPase activity plays a key role in the pathobiology of LRRK2
-
PID: 20386743
-
Xiong Y, Coombes CE, Kilaru A, et al. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet 2010;6:e1000902.
-
(2010)
PLoS Genet
, vol.6
, pp. e1000902
-
-
Xiong, Y.1
Coombes, C.E.2
Kilaru, A.3
-
112
-
-
84891776413
-
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies
-
PID: 24403142, COI: 1:CAS:528:DC%2BC2cXns1Wqug%3D%3D
-
Skibinski G, Nakamura K, Cookson MR, Finkbeiner S. Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J Neurosci 2014;34:418-433.
-
(2014)
J Neurosci
, vol.34
, pp. 418-433
-
-
Skibinski, G.1
Nakamura, K.2
Cookson, M.R.3
Finkbeiner, S.4
-
113
-
-
77956441086
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
-
PID: 20729864, COI: 1:CAS:528:DC%2BC3cXhtVGgtLbE
-
Lee BD, Shin JH, VanKampen J, et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 2010;16:998-1000.
-
(2010)
Nat Med
, vol.16
, pp. 998-1000
-
-
Lee, B.D.1
Shin, J.H.2
VanKampen, J.3
-
114
-
-
40649108102
-
A Drosophila model for LRRK2-linked parkinsonism
-
PID: 18258746, COI: 1:CAS:528:DC%2BD1cXis1yju7c%3D
-
Liu Z, Wang X, Yu Y, et al. A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci U S A 2008;105:2693-2698.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 2693-2698
-
-
Liu, Z.1
Wang, X.2
Yu, Y.3
-
115
-
-
77957377567
-
LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ss
-
PID: 20881132, COI: 1:CAS:528:DC%2BC3cXht1KisLnJ
-
Lin CH, Tsai PI, Wu RM, Chien CT. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ss. J Neurosci 2010;30:13138-13149.
-
(2010)
J Neurosci
, vol.30
, pp. 13138-13149
-
-
Lin, C.H.1
Tsai, P.I.2
Wu, R.M.3
Chien, C.T.4
-
116
-
-
80053152848
-
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
-
PID: 21768216, COI: 1:CAS:528:DC%2BC3MXht1ajtbnL
-
Liu Z, Hamamichi S, Lee BD, et al. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Hum Mol Genet 2011;20:3933-3942.
-
(2011)
Hum Mol Genet
, vol.20
, pp. 3933-3942
-
-
Liu, Z.1
Hamamichi, S.2
Lee, B.D.3
-
117
-
-
70349103837
-
Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila
-
PID: 19741132, COI: 1:CAS:528:DC%2BD1MXhtFOhu7vO
-
Ng CH, Mok SZ, Koh C, et al. Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 2009;29:11257-11262.
-
(2009)
J Neurosci
, vol.29
, pp. 11257-11262
-
-
Ng, C.H.1
Mok, S.Z.2
Koh, C.3
-
118
-
-
84898622052
-
Ribosomal protein s15 phosphorylation mediates lrrk2 neurodegeneration in Parkinson's disease
-
PID: 24725412, COI: 1:CAS:528:DC%2BC2cXmslalsr0%3D
-
Martin I, Kim JW, Lee BD, et al. Ribosomal protein s15 phosphorylation mediates lrrk2 neurodegeneration in Parkinson's disease. Cell 2014;157:472-485.
-
(2014)
Cell
, vol.157
, pp. 472-485
-
-
Martin, I.1
Kim, J.W.2
Lee, B.D.3
-
119
-
-
84867649477
-
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations
-
PID: 23082216, COI: 1:CAS:528:DC%2BC38Xhs1ansbjJ
-
Trancikova A, Mamais A, Webber PJ, et al. Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations. PLoS One 2012;7:e47784.
-
(2012)
PLoS One
, vol.7
, pp. e47784
-
-
Trancikova, A.1
Mamais, A.2
Webber, P.J.3
-
120
-
-
77955842871
-
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
-
PID: 20382224, COI: 1:CAS:528:DC%2BC3cXhtVGrt7rE
-
Yao C, El Khoury R, Wang W, et al. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease. Neurobiol Dis 2010;40:73-81.
-
(2010)
Neurobiol Dis
, vol.40
, pp. 73-81
-
-
Yao, C.1
El Khoury, R.2
Wang, W.3
-
121
-
-
67651171368
-
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans
-
PID: 19625511, COI: 1:CAS:528:DC%2BD1MXptlentLo%3D
-
Saha S, Guillily MD, Ferree A, et al. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 2009;29:9210-9218.
-
(2009)
J Neurosci
, vol.29
, pp. 9210-9218
-
-
Saha, S.1
Guillily, M.D.2
Ferree, A.3
-
122
-
-
70350683754
-
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
-
PID: 19692353, COI: 1:CAS:528:DC%2BD1MXhtlWhu7bK
-
Venderova K, Kabbach G, Abdel-Messih E, et al. Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease. Hum Mol Genet 2009;18:4390-4404.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 4390-4404
-
-
Venderova, K.1
Kabbach, G.2
Abdel-Messih, E.3
-
123
-
-
78751522558
-
A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2
-
PID: 21248115, COI: 1:CAS:528:DC%2BC3MXhsVemtrw%3D
-
Dusonchet J, Kochubey O, Stafa K, et al. A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. J Neurosci 2011;31:907-912.
-
(2011)
J Neurosci
, vol.31
, pp. 907-912
-
-
Dusonchet, J.1
Kochubey, O.2
Stafa, K.3
-
124
-
-
79953758383
-
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2
-
PID: 21494637, COI: 1:CAS:528:DC%2BC3MXkvFKjtbg%3D
-
Ramonet D, Daher JP, Lin BM, et al. Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One 2011;6:e18568.
-
(2011)
PLoS One
, vol.6
, pp. e18568
-
-
Ramonet, D.1
Daher, J.P.2
Lin, B.M.3
-
125
-
-
84866065925
-
(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
-
PID: 22539006, COI: 1:CAS:528:DC%2BC38XhtlWqsrfN
-
Chen CY, Weng YH, Chien KY, et al. (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD. Cell Death Differ 2012;19:1623-1633.
-
(2012)
Cell Death Differ
, vol.19
, pp. 1623-1633
-
-
Chen, C.Y.1
Weng, Y.H.2
Chien, K.Y.3
-
126
-
-
84862230156
-
The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities
-
PID: 22534020, COI: 1:CAS:528:DC%2BC38XhvVSiurnL
-
Maekawa T, Mori S, Sasaki Y, et al. The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities. Mol Neurodegener 2012;7:15.
-
(2012)
Mol Neurodegener
, vol.7
, pp. 15
-
-
Maekawa, T.1
Mori, S.2
Sasaki, Y.3
-
127
-
-
67649813448
-
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease
-
PID: 19503083, COI: 1:CAS:528:DC%2BD1MXntVWis7Y%3D
-
Li Y, Liu W, Oo TF, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009;12:826-828.
-
(2009)
Nat Neurosci
, vol.12
, pp. 826-828
-
-
Li, Y.1
Liu, W.2
Oo, T.F.3
-
128
-
-
84880750830
-
Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R(1)(4)(4)(1)G) transgenic mouse
-
PID: 23721786, COI: 1:CAS:528:DC%2BC3sXhtVKntLbL
-
Dranka BP, Gifford A, Ghosh A, et al. Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R(1)(4)(4)(1)G) transgenic mouse. Neurosci Lett 2013;549:57-62.
-
(2013)
Neurosci Lett
, vol.549
, pp. 57-62
-
-
Dranka, B.P.1
Gifford, A.2
Ghosh, A.3
-
129
-
-
70149124508
-
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
-
PID: 19667187, COI: 1:CAS:528:DC%2BD1MXhtFWrs7zP
-
Tong Y, Pisani A, Martella G, et al. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci U S A 2009;106:14622-14627.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 14622-14627
-
-
Tong, Y.1
Pisani, A.2
Martella, G.3
-
130
-
-
34250199013
-
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain
-
PID: 17512502, COI: 1:CAS:528:DC%2BD2sXmsFKqsr8%3D
-
Higashi S, Biskup S, West AB, et al. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res 2007;1155:208-219.
-
(2007)
Brain Res
, vol.1155
, pp. 208-219
-
-
Higashi, S.1
Biskup, S.2
West, A.B.3
-
131
-
-
33845796537
-
Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain
-
PID: 17101029, COI: 1:CAS:528:DC%2BD2sXhsFaks70%3D
-
Higashi S, Moore DJ, Colebrooke RE, et al. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem 2007;100:368-381.
-
(2007)
J Neurochem
, vol.100
, pp. 368-381
-
-
Higashi, S.1
Moore, D.J.2
Colebrooke, R.E.3
-
132
-
-
33645790701
-
LRRK2 expression linked to dopamine-innervated areas
-
PID: 16532471, COI: 1:CAS:528:DC%2BD28XktFWjs7o%3D
-
Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L. LRRK2 expression linked to dopamine-innervated areas. Ann Neurol 2006;59:714-719.
-
(2006)
Ann Neurol
, vol.59
, pp. 714-719
-
-
Galter, D.1
Westerlund, M.2
Carmine, A.3
Lindqvist, E.4
Sydow, O.5
Olson, L.6
-
133
-
-
33646146878
-
Anatomical localization of leucine-rich repeat kinase 2 in mouse brain
-
PID: 16504409, COI: 1:CAS:528:DC%2BD28XktVygt74%3D
-
Melrose H, Lincoln S, Tyndall G, Dickson D, Farrer M. Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 2006;139:791-794.
-
(2006)
Neuroscience
, vol.139
, pp. 791-794
-
-
Melrose, H.1
Lincoln, S.2
Tyndall, G.3
Dickson, D.4
Farrer, M.5
-
134
-
-
33745917404
-
Distribution of PINK1 and LRRK2 in rat and mouse brain
-
PID: 16771836, COI: 1:CAS:528:DC%2BD28XovFGhtrY%3D
-
Taymans JM, Van den Haute C, Baekelandt V. Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 2006;98:951-961.
-
(2006)
J Neurochem
, vol.98
, pp. 951-961
-
-
Taymans, J.M.1
Van den Haute, C.2
Baekelandt, V.3
-
135
-
-
33749463769
-
LRRK2 expression in normal and pathologic human brain and in human cell lines
-
PID: 17021400, COI: 1:CAS:528:DC%2BD28XhtFOrsLfI
-
Miklossy J, Arai T, Guo JP, et al. LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol 2006;65:953-963.
-
(2006)
J Neuropathol Exp Neurol
, vol.65
, pp. 953-963
-
-
Miklossy, J.1
Arai, T.2
Guo, J.P.3
-
136
-
-
78649750585
-
A comparative study of Lrrk2 function in primary neuronal cultures
-
PID: 20850369
-
Dachsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ. A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord 2010;16:650-655.
-
(2010)
Parkinsonism Relat Disord
, vol.16
, pp. 650-655
-
-
Dachsel, J.C.1
Behrouz, B.2
Yue, M.3
Beevers, J.E.4
Melrose, H.L.5
Farrer, M.J.6
-
137
-
-
79955544006
-
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2)
-
PID: 21454543, COI: 1:CAS:528:DC%2BC3MXlsVWis78%3D
-
Chan D, Citro A, Cordy JM, Shen GC, Wolozin B. Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem 2011;286:16140-16149.
-
(2011)
J Biol Chem
, vol.286
, pp. 16140-16149
-
-
Chan, D.1
Citro, A.2
Cordy, J.M.3
Shen, G.C.4
Wolozin, B.5
-
138
-
-
84856404449
-
LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth
-
PID: 22303461, COI: 1:CAS:528:DC%2BC38XitlyqsL4%3D
-
Kawakami F, Yabata T, Ohta E, et al. LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth. PLoS One 2012;7:e30834.
-
(2012)
PLoS One
, vol.7
, pp. e30834
-
-
Kawakami, F.1
Yabata, T.2
Ohta, E.3
-
139
-
-
84865341866
-
LRRK2 I2020T mutation is associated with tau pathology
-
PID: 22525366
-
Ujiie S, Hatano T, Kubo S, et al. LRRK2 I2020T mutation is associated with tau pathology. Parkinsonism Relat Disord 2012;18:819-823.
-
(2012)
Parkinsonism Relat Disord
, vol.18
, pp. 819-823
-
-
Ujiie, S.1
Hatano, T.2
Kubo, S.3
-
140
-
-
39549117093
-
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
-
PID: 18182054, COI: 1:CAS:528:DC%2BD1cXlsl2gs7g%3D
-
Plowey ED, Cherra SJ, 3rd, Liu YJ, Chu CT. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 2008;105:1048-1056.
-
(2008)
J Neurochem
, vol.105
, pp. 1048-1056
-
-
Plowey, E.D.1
Cherra, S.J.2
Liu, Y.J.3
Chu, C.T.4
-
141
-
-
33845298032
-
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
-
PID: 17120249, COI: 1:CAS:528:DC%2BD2sXkt1alsw%3D%3D
-
Biskup S, Moore DJ, Celsi F, et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 2006;60:557-569.
-
(2006)
Ann Neurol
, vol.60
, pp. 557-569
-
-
Biskup, S.1
Moore, D.J.2
Celsi, F.3
-
142
-
-
70349991886
-
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
-
PID: 19640926, COI: 1:CAS:528:DC%2BD1MXht1CrtrvN
-
Alegre-Abarrategui J, Christian H, Lufino MM, et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 2009;18:4022-4034.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 4022-4034
-
-
Alegre-Abarrategui, J.1
Christian, H.2
Lufino, M.M.3
-
143
-
-
84863241584
-
Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
-
PID: 22171073, COI: 1:CAS:528:DC%2BC38XivVejtL0%3D
-
Dodson MW, Zhang T, Jiang C, Chen S, Guo M. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum Mol Genet 2012;21:1350-1363.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1350-1363
-
-
Dodson, M.W.1
Zhang, T.2
Jiang, C.3
Chen, S.4
Guo, M.5
-
144
-
-
80051534540
-
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease
-
PID: 21763483, COI: 1:CAS:528:DC%2BC3MXovF2mt7k%3D
-
Zimprich A, Benet-Pages A, Struhal W, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011;89:168-175.
-
(2011)
Am J Hum Genet
, vol.89
, pp. 168-175
-
-
Zimprich, A.1
Benet-Pages, A.2
Struhal, W.3
-
146
-
-
84888852586
-
Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation
-
PID: 24211199, COI: 1:CAS:528:DC%2BC3sXhvVSmu7nJ
-
Manzoni C, Mamais A, Dihanich S, et al. Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation. Biochem Biophys Res Commun 2013;441:862-866.
-
(2013)
Biochem Biophys Res Commun
, vol.441
, pp. 862-866
-
-
Manzoni, C.1
Mamais, A.2
Dihanich, S.3
-
147
-
-
33947663512
-
LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins
-
PID: 17346966, COI: 1:CAS:528:DC%2BD2sXjslGnu78%3D
-
Sakaguchi-Nakashima A, Meir JY, Jin Y, Matsumoto K, Hisamoto N. LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr Biol 2007;17:592-598.
-
(2007)
Curr Biol
, vol.17
, pp. 592-598
-
-
Sakaguchi-Nakashima, A.1
Meir, J.Y.2
Jin, Y.3
Matsumoto, K.4
Hisamoto, N.5
-
148
-
-
0029416828
-
The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization
-
PID: 8533093, COI: 1:CAS:528:DyaK28XltlSg
-
Cukierman E, Huber I, Rotman M, Cassel D. The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization. Science 1995;270:1999-2002.
-
(1995)
Science
, vol.270
, pp. 1999-2002
-
-
Cukierman, E.1
Huber, I.2
Rotman, M.3
Cassel, D.4
-
149
-
-
3142523461
-
COP and clathrin-coated vesicle budding: different pathways, common approaches
-
PID: 15261670, COI: 1:CAS:528:DC%2BD2cXlsl2lurw%3D
-
McMahon HT, Mills IG. COP and clathrin-coated vesicle budding: different pathways, common approaches. Curr Opin Cell Biol 2004;16:379-391.
-
(2004)
Curr Opin Cell Biol
, vol.16
, pp. 379-391
-
-
McMahon, H.T.1
Mills, I.G.2
-
150
-
-
72149087091
-
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein
-
PID: 20064389, COI: 1:CAS:528:DC%2BC3cXkvVyqu7g%3D
-
Lin X, Parisiadou L, Gu XL, et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 2009;64:807-827.
-
(2009)
Neuron
, vol.64
, pp. 807-827
-
-
Lin, X.1
Parisiadou, L.2
Gu, X.L.3
-
151
-
-
84894322830
-
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
-
PID: 24510904, COI: 1:CAS:528:DC%2BC2cXivFaitLo%3D
-
Beilina A, Rudenko IN, Kaganovich A, et al. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A 2014;111:2626-2631.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 2626-2631
-
-
Beilina, A.1
Rudenko, I.N.2
Kaganovich, A.3
-
152
-
-
46549089664
-
LRRK2 regulates synaptic vesicle endocytosis
-
PID: 18445495, COI: 1:CAS:528:DC%2BD1cXnt1OmurY%3D
-
Shin N, Jeong H, Kwon J, et al. LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 2008;314:2055-2065.
-
(2008)
Exp Cell Res
, vol.314
, pp. 2055-2065
-
-
Shin, N.1
Jeong, H.2
Kwon, J.3
-
154
-
-
84887506882
-
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
-
PID: 24148854, COI: 1:CAS:528:DC%2BC2cXjt1Ojsw%3D%3D
-
Sanders LH, Laganiere J, Cooper O, et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction. Neurobiol Dis 2014;62:381-386.
-
(2014)
Neurobiol Dis
, vol.62
, pp. 381-386
-
-
Sanders, L.H.1
Laganiere, J.2
Cooper, O.3
-
155
-
-
78650025189
-
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
-
PID: 21115957, COI: 1:CAS:528:DC%2BC3cXhsFSlu7vM
-
Mortiboys H, Johansen KK, Aasly JO, Bandmann O. Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 2010;75:2017-2020.
-
(2010)
Neurology
, vol.75
, pp. 2017-2020
-
-
Mortiboys, H.1
Johansen, K.K.2
Aasly, J.O.3
Bandmann, O.4
-
156
-
-
80052828693
-
Kinases as targets for Parkinson's disease: from genetics to therapy
-
PID: 21838679, COI: 1:CAS:528:DC%2BC3MXht12hu77J
-
Vancraenenbroeck R, Lobbestael E, Maeyer MD, Baekelandt V, Taymans JM. Kinases as targets for Parkinson's disease: from genetics to therapy. CNS Neurol Disord Drug Targets 2011;10:724-740.
-
(2011)
CNS Neurol Disord Drug Targets
, vol.10
, pp. 724-740
-
-
Vancraenenbroeck, R.1
Lobbestael, E.2
Maeyer, M.D.3
Baekelandt, V.4
Taymans, J.M.5
-
157
-
-
80054977424
-
Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons
-
PID: 21812418, COI: 1:CAS:528:DC%2BC3MXhtVSrtLzP
-
Ramsden N, Perrin J, Ren Z, et al. Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol 2011;6:1021-1028.
-
(2011)
ACS Chem Biol
, vol.6
, pp. 1021-1028
-
-
Ramsden, N.1
Perrin, J.2
Ren, Z.3
-
158
-
-
79952918505
-
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
-
PID: 21378983, COI: 1:CAS:528:DC%2BC3MXkvVKqsL0%3D
-
Deng X, Dzamko N, Prescott A, et al. Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol 2011;7:203-205.
-
(2011)
Nat Chem Biol
, vol.7
, pp. 203-205
-
-
Deng, X.1
Dzamko, N.2
Prescott, A.3
-
159
-
-
84858791638
-
Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models
-
PID: 22860184, COI: 1:CAS:528:DC%2BC38XosFentA%3D%3D
-
Kramer T, Lo Monte F, Goring S, Okala Amombo GM, Schmidt B. Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models. ACS Chem Neurosci 2012;3:151-160.
-
(2012)
ACS Chem Neurosci
, vol.3
, pp. 151-160
-
-
Kramer, T.1
Lo Monte, F.2
Goring, S.3
Okala Amombo, G.M.4
Schmidt, B.5
-
160
-
-
84865032690
-
Brain penetrant LRRK2 inhibitor
-
PID: 23066449, COI: 1:CAS:528:DC%2BC38XoslamtL0%3D
-
Choi HG, Zhang J, Deng X, et al. Brain penetrant LRRK2 inhibitor. ACS Med Chem Lett 2012;3:658-662.
-
(2012)
ACS Med Chem Lett
, vol.3
, pp. 658-662
-
-
Choi, H.G.1
Zhang, J.2
Deng, X.3
-
161
-
-
84879419522
-
Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2
-
PID: 23768909, COI: 1:CAS:528:DC%2BC3sXpsV2isrg%3D
-
Troxler T, Greenidge P, Zimmermann K, et al. Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2. Bioorg Med Chem Lett 2013;23:4085-90.
-
(2013)
Bioorg Med Chem Lett
, vol.23
, pp. 4085-4090
-
-
Troxler, T.1
Greenidge, P.2
Zimmermann, K.3
-
162
-
-
84870051317
-
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors
-
PID: 22985112, COI: 1:CAS:528:DC%2BC38XhtlGktbfO
-
Estrada AA, Liu X, Baker-Glenn C, et al. Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem 2012;55:9416-9433.
-
(2012)
J Med Chem
, vol.55
, pp. 9416-9433
-
-
Estrada, A.A.1
Liu, X.2
Baker-Glenn, C.3
-
163
-
-
40949145205
-
Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease
-
PID: 18272292, COI: 1:CAS:528:DC%2BD1cXjs1Kqur4%3D
-
Westerlund M, Belin AC, Anvret A, Bickford P, Olson L, Galter D. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease. Neuroscience 2008;152:429-436.
-
(2008)
Neuroscience
, vol.152
, pp. 429-436
-
-
Westerlund, M.1
Belin, A.C.2
Anvret, A.3
Bickford, P.4
Olson, L.5
Galter, D.6
-
164
-
-
84857285604
-
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
-
PID: 22361010, COI: 1:CAS:528:DC%2BC38XlsVams7k%3D
-
Rudenko IN, Chia R, Cookson MR. Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? BMC Med 2012;10:20.
-
(2012)
BMC Med
, vol.10
, pp. 20
-
-
Rudenko, I.N.1
Chia, R.2
Cookson, M.R.3
-
165
-
-
84862703407
-
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
-
PID: 22578536, COI: 1:CAS:528:DC%2BC38XmvFeqtLg%3D
-
Lee BD, Dawson VL, Dawson TM. Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease. Trends Pharmacol Sci 2012;33:365-373.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 365-373
-
-
Lee, B.D.1
Dawson, V.L.2
Dawson, T.M.3
-
166
-
-
69449084089
-
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
-
PID: 19684592, COI: 1:CAS:528:DC%2BD1MXpvFCrt7c%3D
-
Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 2009;12:1129-1135.
-
(2009)
Nat Neurosci
, vol.12
, pp. 1129-1135
-
-
Tain, L.S.1
Mortiboys, H.2
Tao, R.N.3
Ziviani, E.4
Bandmann, O.5
Whitworth, A.J.6
-
167
-
-
80052780004
-
Translation initiator EIF4G1 mutations in familial Parkinson disease
-
PID: 21907011, COI: 1:CAS:528:DC%2BC3MXhtFGlsbjL
-
Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 2011;89:398-406.
-
(2011)
Am J Hum Genet
, vol.89
, pp. 398-406
-
-
Chartier-Harlin, M.C.1
Dachsel, J.C.2
Vilarino-Guell, C.3
-
168
-
-
77949897463
-
The progression of pathology in Parkinson's disease
-
PID: 20146698
-
Halliday GM, McCann H. The progression of pathology in Parkinson's disease. Ann N Y Acad Sci 2010;1184:188-195.
-
(2010)
Ann N Y Acad Sci
, vol.1184
, pp. 188-195
-
-
Halliday, G.M.1
McCann, H.2
-
169
-
-
57649188649
-
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
-
PID: 18986508
-
Latourelle JC, Sun M, Lew MF, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med 2008;6:32.
-
(2008)
BMC Med
, vol.6
, pp. 32
-
-
Latourelle, J.C.1
Sun, M.2
Lew, M.F.3
-
170
-
-
34147125812
-
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease
-
PID: 17215492, COI: 1:STN:280:DC%2BD2s7pvFWlug%3D%3D
-
Goldwurm S, Zini M, Mariani L, et al. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 2007;68:1141-1143.
-
(2007)
Neurology
, vol.68
, pp. 1141-1143
-
-
Goldwurm, S.1
Zini, M.2
Mariani, L.3
-
171
-
-
84866510734
-
LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis
-
PID: 22998870, COI: 1:CAS:528:DC%2BC38Xhtl2gtrnI
-
Matta S, Van Kolen K, da Cunha R, et al. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 2012;75:1008-1021.
-
(2012)
Neuron
, vol.75
, pp. 1008-1021
-
-
Matta, S.1
Van Kolen, K.2
da Cunha, R.3
-
172
-
-
84863728713
-
Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein
-
PID: 22639965, COI: 1:CAS:528:DC%2BC38XhtFeis7fL
-
Niu J, Yu M, Wang C, Xu Z. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein. J Neurochem 2012;122:650-658.
-
(2012)
J Neurochem
, vol.122
, pp. 650-658
-
-
Niu, J.1
Yu, M.2
Wang, C.3
Xu, Z.4
-
173
-
-
84859259002
-
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
-
PID: 22228096, COI: 1:CAS:528:DC%2BC38XkvVeqsL4%3D
-
Wang X, Yan MH, Fujioka H, et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 2012;21:1931-1944.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1931-1944
-
-
Wang, X.1
Yan, M.H.2
Fujioka, H.3
-
174
-
-
84891923527
-
A direct interaction between leucine-rich repeat kinase 2 and specific beta-tubulin isoforms regulates tubulin acetylation
-
PID: 24275654, COI: 1:CAS:528:DC%2BC2cXnsFOruw%3D%3D
-
Law BM, Spain VA, Leinster VH, et al. A direct interaction between leucine-rich repeat kinase 2 and specific beta-tubulin isoforms regulates tubulin acetylation. J Biol Chem 2014;289:895-908.
-
(2014)
J Biol Chem
, vol.289
, pp. 895-908
-
-
Law, B.M.1
Spain, V.A.2
Leinster, V.H.3
-
175
-
-
84872362045
-
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
-
PID: 22773119, COI: 1:CAS:528:DC%2BC3sXhsFWhtA%3D%3D
-
Bravo-San Pedro JM, Niso-Santano M, Gomez-Sanchez R, et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci 2013;70:121-136.
-
(2013)
Cell Mol Life Sci
, vol.70
, pp. 121-136
-
-
Bravo-San Pedro, J.M.1
Niso-Santano, M.2
Gomez-Sanchez, R.3
|